Home > Insider Trading > Filing (0001179110-13-012438)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1130598	Onconova Therapeutics Inc.	ONTX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1290208	B Michael Hoffman	712 Fifth Avenue, 36Th Floor New York NY 10019		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-07-30	83,857	$0.00	728,517	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	105,363	$0.00	833,880	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	266,712	$0.00	1,100,592	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	476,087	$0.00	1,576,679	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	85,744	$0.00	1,662,423	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	84,530	$0.00	1,746,953	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust)
Common Stock	Acquisiton	2013-07-30	172,411	$0.00	1,919,364	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	226,024	$0.00	2,145,388	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	1,226,942	$0.00	3,372,330	No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
Common Stock	Acquisiton	2013-07-30	1,000,000	$15.00	4,372,330	No	4	P	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust)
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	C	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust
No	4	P	Indirect	By The Michael and Jane Hoffman 2013 Descendants Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Disposition	2013-07-30	99,350	$0.00	83,857	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2013-07-30	140,449	$0.00	105,363	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2013-07-30	355,528	$0.00	266,712	$0.00
Common Stock	Series E Covertible Preferred Stock	Disposition	2013-07-30	634,625	$0.00	476,087	$0.00
Common Stock	Series F Convertible Preferred Stock	Disposition	2013-07-30	111,227	$0.00	85,744	$0.00
Common Stock	Series F Convertible Preferred Stock	Disposition	2013-07-30	109,653	$0.00	84,530	$0.00
Common Stock	Series G Convertible Preferred Stock	Disposition	2013-07-30	229,825	$0.00	172,411	$0.00
Common Stock	Series H COnvertible Preferred Stock	Disposition	2013-07-30	301,290	$0.00	226,024	$0.00
Common Stock	Series I Convertible Preferred Stock	Disposition	2013-07-30	1,635,514	$0.00	1,226,942	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
109,653	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect
0	No	4	C	Indirect

Footnotes

The Series B Convertible Preferred Stock converted into Common Stock on a 0.85-for-1 basis and had no expiration date.
The Series C Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.
The Series D Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.
The Series E Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.
The Series F Convertible Preferred Stock converted into Common Stock on a 0.77-for-1 basis and had no expiration date.
The Series G Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.
The Series H Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.
The Series I Convertible Preferred Stock converted into Common Stock on a 0.75-for-1 basis and had no expiration date.
These shares are held in a trust for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.